AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $152,356,166 | +21.5% | 3,012,182 | +12.1% | 0.00% | +33.3% |
Q2 2023 | $125,403,458 | +53.2% | 2,685,874 | +25.6% | 0.00% | +50.0% |
Q1 2023 | $81,834,046 | -29.4% | 2,138,893 | +1.1% | 0.00% | -33.3% |
Q4 2022 | $115,988,091 | +95.7% | 2,116,571 | +21.6% | 0.00% | +50.0% |
Q3 2022 | $59,267,000 | +378.4% | 1,740,593 | +32.8% | 0.00% | – |
Q2 2022 | $12,389,000 | -28.8% | 1,311,014 | +6.9% | 0.00% | – |
Q1 2022 | $17,410,000 | -29.7% | 1,226,911 | +4.8% | 0.00% | -100.0% |
Q4 2021 | $24,755,000 | +2.5% | 1,170,419 | +8.3% | 0.00% | 0.0% |
Q3 2021 | $24,151,000 | -8.1% | 1,080,585 | +2.0% | 0.00% | 0.0% |
Q2 2021 | $26,290,000 | -8.1% | 1,059,636 | +7.5% | 0.00% | 0.0% |
Q1 2021 | $28,595,000 | +25.4% | 985,720 | +11.6% | 0.00% | 0.0% |
Q4 2020 | $22,796,000 | -13.3% | 883,563 | +3.5% | 0.00% | 0.0% |
Q3 2020 | $26,288,000 | +95.3% | 853,773 | +58.1% | 0.00% | – |
Q2 2020 | $13,459,000 | +107.0% | 540,076 | +76.1% | 0.00% | – |
Q1 2020 | $6,503,000 | +3.0% | 306,719 | +7.8% | 0.00% | – |
Q4 2019 | $6,316,000 | +50.5% | 284,596 | +54.2% | 0.00% | – |
Q3 2019 | $4,198,000 | +631.4% | 184,525 | +515.1% | 0.00% | – |
Q2 2019 | $574,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |